Pfizer, BioNTech file for FDA approval of COVID booster shot
pharmaphorum
AUGUST 16, 2021
Pfizer and BioNTech have formally asked for FDA approval of a third dose of their COVID-19 vaccine BNT162b2 in people aged over 16, as the US prepares to get its booster campaign underway. The post Pfizer, BioNTech file for FDA approval of COVID booster shot appeared first on.
Let's personalize your content